A61P 5/10
Drugs for disorders of the endocrine system: of the posterior pituitary hormones
Official title: of the posterior pituitary hormones, e.g. oxytocin, ADH
A61P5/10 (Drugs for disorders of the endocrine system: of the posterior pituitary hormones) appears on 572 US grants and 777 published applications in this corpus.
Search patents in A61P- Granted patents
- 572
- Published applications
- 777
- Assignees
- 344
- Inventors
- 1,639
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 4 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 6 | 0 |
| 1996 | 10 | 0 |
| 1997 | 9 | 0 |
| 1998 | 15 | 0 |
| 1999 | 17 | 0 |
| 2000 | 13 | 0 |
| 2001 | 17 | 4 |
| 2002 | 18 | 33 |
| 2003 | 19 | 44 |
| 2004 | 15 | 56 |
| 2005 | 25 | 38 |
| 2006 | 20 | 47 |
| 2007 | 21 | 35 |
| 2008 | 21 | 67 |
| 2009 | 22 | 60 |
| 2010 | 20 | 45 |
| 2011 | 27 | 37 |
| 2012 | 34 | 44 |
| 2013 | 33 | 30 |
| 2014 | 35 | 44 |
| 2015 | 28 | 34 |
| 2016 | 24 | 29 |
| 2017 | 22 | 30 |
| 2018 | 18 | 16 |
| 2019 | 18 | 17 |
| 2020 | 10 | 14 |
| 2021 | 8 | 14 |
| 2022 | 7 | 5 |
| 2023 | 4 | 10 |
| 2024 | 4 | 10 |
| 2025 | 5 | 8 |
| 2026 | 2 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Specification of functional cranial placode derivatives from human pluripotent stem cells5 May 2026US 12,618,044 B2Memorial Sloan Kettering Cancer Center
- Pharmaceutical preparation6 Jan 2026US 12,516,094 B2Ferring International Center S.A.
- Methods and compositions for inhibiting CD32B expressing cells in IgG4-related diseases30 Dec 2025US 12,509,518 B2Xencor, Inc.
- Method for producing cell mass including pituitary tissue, and cell mass thereof2 Dec 2025US 12,485,147 B2Sumitomo Chemical Company, Limited
- Pharmaceutical compositions29 Apr 2025US 12,285,460 B2Rhythm Pharmaceuticals, Inc.
- Imine compounds as well as preparation method therefor and use thereof27 Aug 2026US 2026/0248763 A1Bio Genuine (Shanghai) Biotech Co., Ltd
- Methods for treating igg4-related diseases27 Aug 2026US 2026/0250393 A1Xencor, Inc.
- Pharmaceutical preparation30 Jul 2026US 2026/0217782 A1Ferring International Center S.A.
- Composition for promoting ghrelin secretion23 Jul 2026US 2026/0206813 A1Meiji Co., Ltd.
- Pharmaceutical compositions26 Feb 2026US 2026/0053885 A1Rhythm Pharmaceuticals, Inc.
Most cited
By later US patents
- Dispersible antibody compositions and methods for their preparation and use351US 6,019,968 AInhale Therapeutic Systems · 2000
- 3-heteroaryl-2-indolinone compounds for the treatment of disease265US 5,792,783 ASugen, Inc. · 1998
- Spray drying of macromolecules to produce inhaleable dry powders220US 6,582,728 B1Inhale Therapeutic Systems · 2003
- Method of producing sustained-release preparation177US 6,267,981 B1Takeda Chemical Industries, Ltd. · 2001
- 3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease169US 5,883,113 ASugen, Inc. · 1999